February 12, 2015 / 1:37 PM / 3 years ago

BRIEF-Novavax initiates phase 1 clinical trial of Ebola vaccine in healthy subjects

Feb 12 (Reuters) - Novavax Inc

* Initiates phase 1 clinical trial of Ebola vaccine in healthy subjects

* Novavax says "Ebola GP Vaccine can be rapidly scaled up to produce millions of doses" Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below